GGrantIndex
Sort

53,477 grants matching addiction

Estradiol signaling pathways mediating sex differences in striatal synaptic plasticity

$608,662
Kim L Blackwell · University Of Iowa · R01 · FY2024 · DA

Genomic mechanisms of decision-making and opioid use trajectories in the rat

$608,659
Ralph J Dileone · Yale University · U01 · FY2024 · DA

Data Mining and Functional Validation of SCORCH Datasets

$608,652
Pietro P Sanna · Scripps Research Institute, The · R01 · FY2025 · DA

Functional connectome analysis of amphetamine action at dopamine neuron synapses

$608,624
Stephen G Rayport · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2016 · DA

Core 1: Administrative Core

$608,589
Bruce R Schackman · Weill Medical Coll Of Cornell Univ · P30 · FY2020 · DA

Mitochondrial calcium signaling in pancreatic cancer metastasis and progression

$608,525
Shengyu Yang · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2024 · CA

A therapeutic workplace for homeless adults with alcohol use disorders

$608,475
Kenneth Silverman · Johns Hopkins University · R01 · FY2018 · AA

Effects of Stereotype Threat on Impulsivity and Its Relation to Alcohol Use in African Americans: An fMRI Study

$608,474
Uraina S Clark · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AA

Anti-inflammatory therapy to improve outcomes in patients with chronic pancreatitis undergoing total pancreatectomy with islet autotransplant (TPIAT)

$608,447
Melena D. Bellin · University Of Minnesota · R01 · FY2017 · DK

Physiology and Pharmacology of Brain Reward Circuits

$608,438
Carl Lupica · National Institute On Drug Abuse · ZIA · FY2018 · DA

A randomized controlled clinical trial of the neuroimmune modulator ibudilast for the treatment of alcohol use disorder

$608,362
Lara Ray · University Of California Los Angeles · R01 · FY2018 · AA

Novel treatments of fracture repair and bone pain

$608,358
Fletcher A White · Indiana University Indianapolis · R01 · FY2024 · AR

Injury of blood brain and alveolar-endothelial barriers caused by alcohol and electronic cigarettes via purinergic receptor signaling

$608,357
Yuri Persidsky · Temple Univ Of The Commonwealth · R01 · FY2024 · AA

3/11 Epigenetic Regulation of Neuroimmune Pathways

$608,350
Sean P Farris · University Of Pittsburgh At Pittsburgh · U01 · FY2023 · AA

In-person vs. Computer Interventions to Increase Probation Compliance

$608,331
Scott T Walters · University Of North Texas Hlth Sci Ctr · R01 · FY2015 · DA

Advancing the science on recovery community centers to support persons treated with medications for opioid use disorder

$608,278
John F Kelly · Massachusetts General Hospital · R24 · FY2021 · DA

Omics analysis of HIV during synthetic opioid exposure

$608,272
Jason T Blackard · University Of Cincinnati · R61 · FY2020 · DA

Evaluating New Nicotine Standards for Cigarettes - Project 2

$608,269
Eric Christian Donny · Wake Forest University Health Sciences · U54 · FY2022 · DA

Muscarinic acetylcholine receptor subtypes: physiological roles

$608,250
Jurgen Wess · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2012 · DK

Presynaptic forms of long-term plasticity in the CNS

$608,199
Pablo E Castillo · Albert Einstein College Of Medicine · R01 · FY2020 · MH

Extended Treatment for Smoking Cessation

$608,190
Joel D Killen · Stanford University · R01 · FY2009 · DA

A Systems Biology Approach to HIV-associated Neurocognitive Impairment: Role of Drug Abuse and Neuroinflammation

$608,153
David Martin Murdoch · Duke University · R01 · FY2020 · DA

Building iCRISP: Indigenous Community-Informed Research Infrastructure to address Substance Misuse and Pain Management

$608,095
Cherry M. Beasley · Lumbee Land Development, Inc. · OT2 · FY2024 · DA

DIRECTLY ADMINISTERED HIV THERAPY IN METHADONE CLINICS

$608,055
Gregory M Lucas · Johns Hopkins University · R01 · FY2008 · DA

HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids

$608,005
Pedro Mateu-Gelabert · National Development And Research Institutes, Inc. · R01 · FY2016 · DA